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Introduction
ins [4] .
We recently diagnosed a patient having a type I cryoglobulinaemia with renal involvement. Because we Cryoglobulins are immunoglobulins that precipitate or were struck by the indolent cause of her illness and gel when serum is cooled to below 37°C [1 ] . The the response to therapy, we describe her disease with precipitate will disappear if serum is heated to 37°C. a review of other cases of type I cryoglobulinaemia This phenomenon of cold-induced precipitation was with renal involvement, which were identified by first described in vitro in 1929, and its association with searching Medline from 1990 until the present and disease was first recognized 4 years later by Wintrobe using relevant references. and Buell [2] . In 1947, Lerner et al. introduced the term cryoglobulins to describe this subset of immunoglobulins [3] . Cryoglobulins were later divided into Case report three major types: in type I the cryoglobulin fraction is a single monoclonal immunoglobulin component,
Our 56-year-old patient had a 10-year history of type II has mixed monoclonal and polyclonal immunoextreme skin rashes on both arms and legs provoked globulin components, and type III has exclusively by cold exposure before she sought medical advice for polyclonal components [4 ] .
this complaint in 1985. Furthermore she had a history Type I cryoglobulins are mostly seen in combination of sinusitis and upper respiratory infections for which with or as a result of multiple myeloma (M Kahler) she was regularly seen and treated by the department or Waldenströ m's macroglobulinaemia, and rarely in of ENT. On physical examination she had a blood other lymphoproliferative disorders [4, 5] . Types II and pressure of 155/90 mmHg and no signs of vasculitis. III cryoglobulinaemias are mostly seen in combination Laboratory examination revealed a normal ESR with autoimmune and infectious diseases, like (9 mm/h), and normal white and red blood cell counts hepatitis C virus, and lymphoreticular malignancies. and platelet counts. Serum creatinine was 74 mmol/l, Manifestations in cryoglobulinaemia include glom-T 4 78 nmol/l, serum cholesterol 7.1 mmol/l, serum total erulonephritis, arthritis, neuropathies, cirrhosis, and protein 60 g/l, and serum albumin 39 g/l. Protein specskin lesions such as vasculitis and thrombosis.
trum: albumin 64%, alpha-1 4%, alpha-2 12%, b 13%, Cutaneous manifestations are present in 67-100% of gamma 7%. Immunoelectrophoresis showed no abnorpatients with cryoglobulinaemia and are frequently the malities, especially no paraprotein. Serum was positive first reason to seek medical advice [4, 6 ] .
for cryoglobulins, which were not further typed. Although particular forms of glomerulonephritis, Syphilisserology was negative. Urine was negative for such as membranoproliferative glomerulonephritis, are albumin. frequently seen in types II and III mixed cryoglobulinaDuring the following years the patient developed emias, renal disorders are relatively infrequent in type I overt skin lesions in addition to rashes. Skin biopsy cryoglobulinaemia [5] . Brouet et al. report renal manirevealed leukocytoclastic vasculitis. She had no general symptoms like fatigue, night-sweats, fever or weight skin lesions. Routine laboratory findings were similar 880-2000 mg/l ), C4 complement 387 (normal, to those in 1985. Immunoelectrophoresis revealed a 160-470 mg/l ), CH50 titre 135 (normal, 68-133%), B 2 IgG-kappa paraprotein. Cryoglobulins were strongly microglobulin 4.0 (normal<2.5 mg/l ), ANCA was positive (3.58 g/l ) and consisted of IgG-kappa.
negative. Urine protein loss still was 7 g/l, while urine C1q-binding test was 30% (normal<10%), comple-protein analysis showed the same monoclonal IgG type ment proteins C1q, C3, C4 were normal. Anti-DNA kappa as in serum. was doubtful on qualitative analysis and negative on
Renal biopsy was performed because of deterioraquantitative analysis. ANCA was negative. Urine tion of kidney function. Microscopic evaluation examination showed no protein in urine.
revealed 18 glomeruli, eight of which were sclerosed Skeletal survey indicated no osteolytic lesions. Bone (Figure 1 ). The other glomeruli showed an increase of marrow examination revealed normal maturation of mesangial matrix and cells, a thickening of the capillary red and white precursor cells. Plasma cells accounted walls with double contours of the basal membrane. for 7.8%. Immunological typing revealed monoclonal Several glomeruli showed adhesions and proliferation IgG-kappa, though not sufficient for multiple myeloma of visceral and parietal epithelium. Accumulation of ( M. Kahler) minor criteria.
homogeneous, granular eosinophilic, PAS-positive Since the patient had already recovered from the material was found in the mesangium, the capillary skin lesions and was in good condition an expectant lumina and in the thickened capillary walls. policy was outlined.
Immunofluorescence demonstrated this material to be In 1992, she was referred to an outpatient clinic for IgG and kappa depositions. Furthermore, IgG was hypercholesterolaemia resistant to dietary measure-observed around the peritubular capillaries as well as ments and simvastatin therapy. She was overweight in the tubular epithelium. The findings were diagnostic ( length 154 cm and weight 66 kg) and had a blood for a membranoproliferative glomerulonephritis due pressure of 180/100 mmHg. Laboratory evaluation to IgG kappa cryoglobulinaemia. showed an ESR of 23 mm/h, normal full blood count, Bone marrow cytology showed increased plasma cholesterol 8.0 mmol/l, HDL 1.38 mmol/l, total serum cells (plasma cells were 24% of total nuclear cells of protein 57 g/l, Waaler-Rose and ANF were negative, the marrow). Skeletal X-ray did not show any osteoprotein loss in urine was 1-3 g/l in 24 hours with slight lytic areas. CT scan of both abdomen and thorax did erythrocyturia. Simvastatin therapy was continued and not show enlarged lymph nodes. Again, no definite atenolol was added to control blood pressure.
diagnosis of multiple myeloma ( M. Kahler) could Throughout 1992 values for serum cholesterol and be made. urine protein loss fluctuated. In April 1993 she was Because of deterioration of renal function and the referred to our outpatient clinic because of hyperten-histopathological findings, we started with melphalan sion and proteinuria. She had a blood pressure of and prednisone therapy. 230/90 mmHg, no signs of peripheral oedema. Detailed
During therapy, renal function increased (creatinine laboratory evaluation revealed an ESR of 60 mm/h, 133 mmol/l, clearance 47 ml/min), protein loss in urine normal full blood count, creatinine 88 mmol/l, choles-fell to 1.3 g/l, while blood pressure normalized. terol 10.1 mmol/l, HDL cholesterol 1.24 mmol/l, tri-Clinically, no signs of vasculitis recurred, although a glyceride 1.48 mmol/l, total serum protein 55.7 g/l, severe Raynaud phenomenon was still present. albumin fraction 34.9, alpha-1, alpha-2, beta-globulins in normal range, gamma-globulin 4.5 (normal, 7-15) and paraprotein. Agar electrophoresis and immunofixation showed a weak band for paraprotein IgG type kappa. Cryoglobulins were again positive; further typing revealed a type I cryoglobulinaemia. ANF was negative, immunofluorescence test and ELISA were negative for ANCA. HCV and HBV were negative. Urine protein loss was 4.3 g/l, erythrocyturia was 30-40 per high-power field. Drug therapy was changed to simvastatin, atenolol, and hydrochlorothiazide.
In the following years renal function slowly deteriorated. In 1995, creatinine clearance fell to 33 ml/min while protein loss had increased to 7 g/24 h. In late 1995, laboratory evaluation showed an ESR of 101 mm/h, Hb 6.3 mmol/l, creatinine 169 mmol/l, total serum protein 61 g/l, serum albumin 35 g/l, alpha-1, alpha-2, beta-globulins within the normal range, gamma-globulins 3 g/l, paraprotein 1 g/l, IgA 0.47 (normal, 75-125 mg/l ), C3 complement 808 (normal,
Literature review Discussion
In this report we describe a 56-year-old woman with a Searching the recent literature on cryoglobulinaemia, more than 10-year history of Raynaud's phenomenon, we found only seven studies with well-defined, histoa well-documented cryoglobulinaemia type I, and renal logically confirmed renal involvement (Table 1 ) . In involvement documented 7 years after her first symptotal, seven patients were described. Six of them were toms. Although a monoclonal IgG kappa production male, only one of them was female. Their mean age was found a definite diagnosis of multiple myeloma was 50 years, the youngest being 35 years old, the could not be made. Nine years after her first disease oldest being 68 year of age at the onset of disease.
manifestations renal function deteriorated. Renal Signs of vasculitis were the presenting symptom in biopsy revealed a membranoproliferative glomerulofour of seven patients. One patient was diagnosed with nephritis. Treatment with melphalan and prednisone Raynaud's phenomenon in the early phase of his was successful. cryoglobulinaemia. Oedema was the presenting sympIn one of the first studies [4 ] published in 1974, 21 tom in three patients.
patients of the 86 patients with cryoglobulinaemia had Histologically all biopsies showed a membranopro-a type I cryoglobulinaemia (25%). IgM cryoglobulins liferative glomerulonephritis. In the case described by were the most frequent within the group of type I Pais et al. [8] , capillary obstruction was observed in cryoglobulinaemia. Twenty-five per cent of the patients addition. Immunological typing revealed IgG cryoglo-with type I cryoglobulinaemia developed renal sympbulinaemia in more than half of the cases. Kappa toms. Since the authors did not specify the renal disease chains were detected by immunological typing in three and the moment of its occurrence, this study is of of seven patients. The interval between the onset of limited value for our case. the cryoglobulinaemia and renal involvement differed Several other studies and case reports on cryoglobulinaemia with renal involvement published in the last from less than 1 year in three cases to 7 years in the two decades could not be used because of lack of case described by Ezzat et al. [11 ] . Except for the fatal typing of the cryoglobulins or because of lack of case described by Pais [8 ], all patients showed initial specification of the renal involvement due to the type improvement on immunosuppressive treatment.
of cryoglobulinaemia. In fact, we only found seven Unfortunately, in three cases [10, 12, 14 ] , the initial studies with well-defined, histologically confirmed renal response did not result in a remission and the deteriorainvolvement, all of them being a membranoproliferation in kidney function led to the start of peritonealtive glomerulonephritis. In only three of seven patients or haemodialysis. In Ezzat's case [11 ], remission was medication resulted in remission of the renal disease. obtained by treating the underlying non-Hodgkin
Compared to the other studies published on renal lymphoma with combination chemotherapy. In the involvement in type I cryoglobulinaemia our case cases described by Bengtsson et al. [13 ] and Ponticelli report is conspicious for the very late onset of kidney et al.
[9 ], remission was followed by maintenance on involvement. Seven years after the first presentation of immunosuppressive therapy. symptoms, our patient developed proteinuria. Two In three of seven patients a malignant lymphoma years later renal function deteriorated. could be diagnosed as the underlying disease of the In the literature only Ezzat et al.
[11 ] described a cryoglobulinaemia [8, 11, 14] . In the four other patients case in which renal involvement was diagnosed 7 years an underlying disorder could not be found or was at after the development of a leukocytoclastic vasculitis. least not mentioned in the report. Diagnosing the However, this patient had been lost for follow up for underlying disease did not improve or amend the several years. When first diagnosed he already had a severe nephrotic syndrome. prognosis and the course of the cryoglobulinaemia. 
